Higher SCORAD 50 responses in the ustekinumab group compared with placebo were found at week 12 and 16, but did not reach statistical significance.
1
—
—
Higher SCORAD 50 responses in the ustekinumab group compared with placebo were found at week 12 and 16, but did not reach statistical significance.